Cirugía del cáncer mamario en pacientes con sobrepeso u obesas

Bibliografía
1. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst. 2006;98:599–609.
2. Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25:3657–3663.
3. Goyal A, Newcombe RG, Chhabra A, et al. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND. Ann Surg Oncol. 2008;15:262–267.
4. El-Tamer MB,Ward BM, Schifftner T, et al. Morbidity and mortality following breast cancer surgery in women. National benchmarks for standards of care. Ann Surg. 2007;245:665–671.
5. Villar-Compte D, Rosales S, Hernandez-Mello N, et al. Surveillance, control, and prevention of surgical site infections in breast cancer surgery: A 5-year experience. Am J Infect Control. 2009;37:674–679.
6. Lefebvre D, Penel N, Deberles MF, et al. Incidence and surgical wound infection risk factors in breast cancer surgery. Presse Medical. 2000;29:1927–1932.
7. Witt A, Yavuz D, Walchetseder C, et al. Preoperative core needle biopsy as an independent risk factor for wound infection after breast surgery. Obstet Gynecol. 2003;101:745–750.
8. Reilly J, Twaddle S, McIntosh J, et al. An economic analysis of surgical wound infection. J Hosp Infect. 2001;49:245–249.
9. Villar-Compte D, Jacquemin B, Robles-Vidal C, et al. Surgical site infections in breast surgery: case-control study. World J Surg. 2004;28:242–246.
10. Olsen MA, Lefta M, Dietz JR, et al. Risk factors for surgical site infection after major breast operation. J Am Coll Surg. 2008;207:326–335.
11. Hall JC, Willsher PC, Hall JL. Randomized clinical trial of single-dose antibiotic prophylaxis for non-reconstructive breast surgery. Br J Surg. 2006;93:1342–1346.
12. Penel N, Yazdanpanah Y, Chauvet MP, et al. Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection. J Surg Oncol. 2007;96:124–129.
13. Wagman LD, Tegtmeier B, Beatty JD, et al. A prospective, randomized double blind study of the use of antibiotics at the time of mastectomy. Surg Gynecol Obstet. 1990;170:12–16.
14. Bold RJ, Mansfield PF, Berger DH, et al. Prospective, randomized, double blind study of prophylactic antibiotics in axillary lymph node dissection. Am J Surg. 1998;176:239–243.
15. Chow LW, Yuen KY, Woo PC, et al. Clarythromycin attenuates mastectomy induced acute inflammatory response. Clin Diagn Lab Immunol. 2000;7:925–931.
16. Gupta R, Sinnet D, Carpenter R, et al. Antibiotic prophylaxis for postoperative wound infection in clean elective breast surgery. Eur J Surg Oncol. 2000;26:363–366.
17. Bunn F, Cunningham ME, Handscomb K. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database Syst Rev. 2006;2:CD005360.
18. Tejirian T, Di Fronzo LA, Haigh PI. Antibiotic prophylaxis for preventing wound infection after breast surgery: a systemic review and metaanalysis. J Am Coll Surg. 2006;203:729–734.
19. Arsalani-Zadeh R, El Fadl D, Yassin N, et al. Evidence-based review of enhancing postoperative recovery after breast surgery. Br J Surg. 2011;98:181–196.
20. Keys A, Fidanza F,Karvonen MJ, et al. Indices of relative weight and adiposity. J Chronic Dis. 1972;25:329–343.
21. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol. 1999;20:247–278.
22. Cruse PJE, Foord R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin N Am. 1980;60:27–40.
23. Gumus M, Ustaalioglu BO, Garip M, et al. Factors that affect patients’ decision making about mastectomy or breast conserving surgery, and the psychological effect of the choice on breast cancer patients. Breast Care. 2010;5:164–168.
24. Platt R, Zaleznik DF, Hopkins CC, et al. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N Eng J Med. 1990;322:153–160.
25. Amland PF, Andenaes K, Samdal F, et al. A prospective, double-blind, placebo controlled trial of a single dose of azithromycin on postoperative wound infections in plastic surgery. Plast Reconstr Surg. 1995;96:1378–1383.
26. World Health Organization. Measuring Obesity, Classification and Description of Anthropometric Data. Copenhagen: WHO; 1989.
27. Mukhtar RA, Throckmorton AD, Alvarado MD, et al. Bacteriologic features of surgical site infections following breast surgery. Am J Surg. 2009;198:529–531.
28. Olsen MA, Chu-Ongsakul S, Brandt KE, et al. Hospital-associated costs due to surgical site infection after breast surgery. Arch Surg. 2008;143:53–60.